ORMP

Oramed Pharmaceuticals: Interesting Late-Stage Oral Insulin Developer

Oramed Pharmaceuticals and Oravax Medical to be Featured in Alliance Global Partners' Grand Rounds: A Webinar in Biotech and Specialty Pharma

Oramed Initiates Second Phase 3 Oral Insulin Study Under the FDA's Approved Dual Concurrent Protocol

ORMP Stock Price Increased Over 40% Pre-Market: Why It Happened

Oramed Shares Gain On COVID-19 Vaccine Joint Venture Pact

Oramed Forms a Joint Venture, Oravax Medical Inc., for the Development of Novel Oral COVID-19 Vaccines

Oramed Doses Patients Across Multiple Sites in Phase 3 Oral Insulin Study